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Abstract 
Objectives: To compare 3T T1 mapping to conventional T2-weighted (T2W) imaging for 
delineating myocardial oedema one week after ST-elevation myocardial infarction (STEMI), 
and to explore the confounding effects of microvascular obstruction (MVO) on each 
technique. 
Methods: T2W spectral attenuated inversion recovery and native T1 mapping were applied in 
10 healthy volunteers and 62 STEMI patients, and late gadolinium enhancement was included 
for infarct localisation at 1 week and at 6 months post-STEMI. Segmental T1 values and T2W 
signal intensity ratios were calculated; oedema volumes and salvage indices were determined 
in patients using image thresholding—a receiver operator characteristic (ROC) derived T1 
threshold, and a 2SD T2W threshold; and the results were compared between patients 
with/without MVO (n=35/27). 
Results: Native T1 mapping delineated oedema with significantly better discriminatory power 
than T2W—as indicated by ROC analysis (area-under-the-curve, AUC = 0.89 vs 0.83, 
p=0.009; and sensitivity/specificity= 83/83% vs 73/73%). The optimal ROC threshold derived 
for T1 mapping was 1241 ms, which gave significantly larger oedema volumes than 2SD T2W 
(p=0.006); with this threshold, patients with and without MVO showed similar oedema 
volumes, but patients with MVO had significantly poorer salvage indices (p<0.05) than those 
without. Neither method was significantly affected by MVO, the volume of which was seen to 
increase exponentially with infarct size. 
Conclusions: Native T1 mapping at 3T can delineate oedema one week post-STEMI, showing 
larger oedema volumes and better discriminatory power than T2W imaging, and it is suitable 
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for quantitative thresholding. Both techniques are robust against MVO-related magnetic 
susceptibility. 
Keywords: acute myocardial infarction; magnetic resonance imaging; myocardium at risk; 
myocardial oedema; microvascular obstruction; T1 mapping.  
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Introduction 
Quantitative T1 mapping has recently emerged as a powerful tool for myocardial tissue 
characterisation,[1] and previous work has already illustrated its utility for delineating 
myocardial oedema in acute myocardial infarction (AMI),[2, 3] and acute stress-induced 
cardiomyopathy patients.[4, 5] We have seen that, in the first 24 hours after acute myocardial 
injury, native T1 mapping assessment of oedema appears to be at least as good as that of T2-
weighted (T2W) short tau inversion recovery imaging,[3] which is the current standard for 
oedema assessment with cardiovascular magnetic resonance (CMR). However, it is still 
unknown whether T1 mapping’s strengths are maintained beyond 24 hours after AMI, as—
despite promising initial studies with T1-weighted imaging at 1.5T—it has not yet been 
studied at this time point.[6] 
A significant shortcoming of T2W-based studies to date is that they identify oedema 
qualitatively, using reference regions in remote myocardium. Such regions are presumed to 
contain healthy tissue, a questionable assumption in patient populations—where risk factors 
can lead to subtle myocardial changes.[7] In contrast, native T1 mapping’s primary strength is 
its quantitative nature, which obviates the need for a reference region and allows for powerful 
parametric thresholding.[4] Such benefits advocate the use of T1 mapping for detecting 
oedematous myocardium; however, this up-and-coming method may yet be confounded by 
microvascular obstruction (MVO), a phenomenon that is frequently seen after AMI.[8] 
Indeed, MVO has already been reported to hinder T2W oedema detection,[9, 10] being 
associated with paramagnetic species—deoxygenated haemoglobin and elemental iron—that 
introduce T2-shortening susceptibility gradients and decrease signal intensity in the T2W-
detected oedema region.[11, 12] MVO’s effects have already been reported in quantitative T2 
mapping studies, where affected regions were indistinguishable from normal myocardium on 
 5       
 
T2 maps.[13] Clearly this phenomenon poses problems for CMR oedema quantification, and 
its potential repercussions for T1 mapping warrant immediate investigation.[14] 
The primary purpose of this prospective study is to determine how native 3T T1 
mapping and T2- weighted (T2W) imaging compare for delineating myocardial oedema, both 
segmentally and volumetrically, one week after ST-elevation myocardial infarction (STEMI). 
The volumetric analysis includes an exploration of suitable pixel thresholding approaches for 
each of the two methods, with comparisons against a typical two-standard-deviation 
technique. Furthermore, features of MVO are investigated, including its effect on T1 
relaxation times and T2W signal intensity ratios. 
 
Materials and Methods 
Patients and Healthy Volunteers 
Sixty two patients with first acute ST-segment elevation myocardial infarction (STEMI) 
were consecutively recruited at [REDACTED FOR PEER REVIEW] from September 2011 
to April 2013 as part of the [REDACTED FOR PEER REVIEW] clinical trial.[15] All 
patients had TIMI 0/1 flow at the time of diagnostic angiography and underwent primary 
percutaneous coronary intervention (PCI) within 12 hours of the onset of chest pain. They 
were scanned one week after myocardial infarction (MI) and again six months later, provided 
that no further revascularisation procedures occurred in the interim. Furthermore, to establish 
the normal range of myocardial T1 values and T2W signal intensity ratios, ten age-matched 
healthy volunteers were recruited: six males, no past medical history, no medication, and 
median heart rate (range) = 65 (50-75) bpm. All participants gave informed consent, and the 
study protocol conformed to the ethical guidelines of the 1975 Declaration of Helsinki as 
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reflected in a priori approval by [REDACTED FOR PEER REVIEW] human research 
committee. 
 
Cardiac Magnetic Resonance Imaging 
CMR was performed using a 3 tesla MRI system (Achieva 3.0T TX, Philips Healthcare, 
Best, Netherlands) with a six-channel cardiac phased-array coil and radiofrequency 
shimming. T2W spectral attenuated inversion recovery (SPAIR) was applied as a short-axis 
stack, with repetition time (TR)/ echo time (TE) = 1600/80 ms, in-plane resolution 1.8 mm × 
2.2 mm, slice thickness/gap = 10/0 mm.[16] A corresponding stack of modified Look-Locker 
inversion recovery (MOLLI) T1 mapping images was acquired with: a 3b(3b)3b(3b)5b 
scheme; balanced steady-state free-precession readout; 35° flip angle; TR/TE = 2.7/1.1 ms; 
in-plane resolution 1.7 mm × 2.1 mm; slice thickness = 10 mm; sensitivity encoding factor = 
2; and cardiac triggering to end diastole. This protocol conformed to the guidelines stipulated 
in the Society for Cardiovascular Magnetic Resonance T1 mapping position statement.[17] 
For infarct localisation in STEMI patients, short-axis late gadolinium enhancement 
(LGE) images were acquired using spoiled gradient echo inversion recovery (25° flip angle; 
TR/TE = 6.1/3.0 ms; in-plane resolution 1.8 mm × 2.2 mm; slice thickness/gap = 8/2 mm) 
within a 10-20 minute window after contrast administration (0.1 mmol kg-1 gadolinium 
diethylenetriaminepentacetate, Gadovist; Bayer, Leverkusen, Germany). Infarct size was 
determined from both the acute scan and the six- month follow-up in order to account for the 
remodelling process. 
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Image Analysis 
T1 maps were generated from MOLLI source images using in-house software (IDL, 
Excelis, Boulder, CO, USA) and controlled for artefacts with the aid of chi-square error 
maps. They were then prepared for segmental analysis, whereby the multi-slice T1 data 
were pooled into basal, mid-cavity, and apical sets, and were segmented according to the 
American Heart Association 17-segment model,[18] omitting the apical cap and including 
MVO, where present. Individual T1 values were calculated for the remaining 16 segments, 
and a blood pool threshold—measured in normal volunteers as the mean left ventricular 
blood pool T1 minus 2SD—was used to exclude pixels contaminated by blood 
contributions. Consistent with T1 mapping, T2-weighted images were segmented and 
examined for artefacts, and reference regions of interest (ROIs) were drawn in pectoral 
muscle for calculation of signal intensity ratios.[19] 
Infarcted (LGE+) segments were identified on LGE images by an experienced 
cardiologist (five years’ experience) as regions with signal intensity greater than the mean 
signal intensity in remote myocardium (diametrically opposite the STEMI area) plus 
5SD.[20] Given that early and late gadolinium enhancement show similar sensitivity and 
specificity for detecting MVO,[10] LGE images were selected for MVO identification. Thus 
LGE+ segments were subdivided according to whether or not they contained MVO (MVO+ 
or MVO-, respectively), which was identified as subendocardial or mid-wall 
hypoenhancement within gadolinium-enhanced myocardium.[21] The total MVO volume 
was expressed as a percentage of the myocardial volume. 
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Inter- and Intra-Observer Reproducibility 
To compare the inter- and intra-observer reproducibility of T1 mapping and T2W-
SPAIR, segmental measurements were repeated in five patients and five volunteers and re-
measured by a second independent and blinded observer (three years’ experience) in those 
same participants. 
 
T1 Mapping versus T2W-SPAIR: Performance for Detecting At-Risk Myocardium 
ROC analysis was performed to assess the discriminatory power of T1 mapping and 
T2W-SPAIR in the entire patient cohort, as well in MVO+/MVO- patient subgroups. LGE 
was considered a surrogate of acute myocardial injury, given that endocardial surface area 
LGE is accepted as a method for measuring area at risk.[22] Therefore, acute (one week post 
STEMI) LGE+ segments were used as the oedema-positive test state, as previously 
described,[3] and normal segments from healthy volunteers were used as the oedema-
negative test state. All T1 map and T2W-SPAIR segments were categorised as LGE+ or LGE-
, and were only included if they were artefact-free in both T1 maps and T2W-SPAIR images. 
ROC thresholds were chosen for equal sensitivity and specificity. 
 
Volume of Myocardium at Risk: T1 Mapping versus T2W-SPAIR  
For T2W-SPAIR volumetric analysis, pixels with signal intensities 2SD higher than the 
mean signal intensity of remote myocardium were considered oedematous,[23] and oedema 
volume was expressed as a percentage of the total myocardial volume. For T1 mapping, two 
methods were used to measure the oedema volume: 1) a 2SD threshold, equivalent to that 
described for T2W-SPAIR; 2) a pre-set threshold, where pixels were considered oedematous 
 9       
 
if their T1 values fell between the ROC-derived threshold and the mean blood pool T1 minus 
2SD. The pre-set threshold also included a window to accommodate haemorrhagic T1 values 
(500-1025 ms), which would otherwise be excluded from the oedema volume, in order to 
mitigate any bias in thevolume calculation. Infarct size was measured on acute and six-month 
LGE images using a 5SD threshold, and was used to calculate salvage index as follows: 
(oedema volume × infarct size) = oedema volume. 
 
Statistical Analysis 
Intra-method comparisons were made in SPSS (IBM, Armonk, NY, USA) using 
analysis of variance, and significant inter-group differences were verified using two-tailed 
independent t-tests or Mann-Whitney U tests. In ROC analysis, area-under-the-curve (AUC) 
values were compared according to Hanley and McNeil.[24] Finally, inter- and intra-observer 
reproducibility were evaluated using Bland-Altman analysis and intra-class correlation 
coefficients (ICC). 
 
Results 
Patient Demographics 
Patient characteristics, risk factors, culprit arteries and CMR characteristics are 
presented in Table 1. MVO+ patients had significantly larger raw and indexed left ventricular 
volumes, (end-systolic p=0.003, end-diastolic p=0.03, indexed end-systolic p=0.001, indexed 
end-diastolic p=0.01), reduced left ventricular ejection fractions (p<0.001), and higher 12 
hour Troponin I levels compared to the MVO- group (p=0.001). There was no significant 
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difference in the time from the onset of chest pain to percutaneous intervention between the 
MVO- and MVO+ groups. 
 
Imaging Results 
Representative images from this study are shown in Figure 1. From a total of 1152 
segments, 382 were discarded from T2W-SPAIR image analysis (5.3 per participant, on 
average) as a result of coil-sensitivity-related signal dropout, which occurred mainly in 
infero-lateral segments. A total of 174 T1 map segments were discarded (2.4 per participant, 
on average): mostly anterior and infero-lateral segments affected by off-resonance artefact 
near the coronary veins. The T1 of normal myocardium in healthy volunteers was seen to be 
significantly shorter (p<0.001) than the T1 of the segments most remote from infarction in 
patients, with mean (SD) T1 values of 1192 (30) ms versus 1215 (39) ms, respectively. The 
mean (SD) blood pool T1 measured in healthy volunteers was 1774 (46) ms, and thus an 
upper pixel threshold of 1682 ms (mean blood pool T1 minus 2SD) was chosen to exclude 
blood pool contamination from myocardial T1 measurements. 
 
Performance for Detecting At-Risk Myocardium and Effect of MVO 
Figure 2 shows ROC analyses, grouped by imaging sequence. For the whole patient 
group, the AUC for T1 mapping was significantly greater than that of T2W-SPAIR (0.89 
versus 0.83, p=0.009), and the calculated oedema threshold T1 was 1241 ms (sensitivity and 
specificity of 83%). For T2W-SPAIR, ROC analysis gave a sensitivity and specificity of 73%. 
Examining MVO- and MVO+ patient groups: in MVO- patients, T1 mapping had  
significantly better discriminatory power than T2W-SPAIR, with an AUC of 0.93 versus 0.81, 
(p=0.004); in MVO+ patients, there was no significant difference between the two 
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techniques, with ROC analysis giving an AUC of 0.88 for T1 mapping versus an AUC of 0.84 
for T2W-SPAIR, (p=0.11). The oedema threshold T1values calculated from these data were 
1243 ms (sensitivity and specificity 86%) in the absence of MVO and 1238 ms (sensitivity 
and specificity 82%) in the presence of MVO. Given the similarity of these values, the 1241 
ms threshold derived from the complete dataset was adopted for volumetric analysis. 
 
Volume of Myocardium at Risk: T1 Mapping versus T2W-SPAIR 
Myocardial oedema volumes and salvage indices derived in all patients using each of 
the three methods are shown in Table 2. The oedema volume measured with T1 mapping-
ROC was significantly larger than that measured with T2W-SPAIR 2SD in the entire group 
(p=0.006) and in the MVO- group (p=0.02), whereas in the MVO+ group no significant 
difference was seen. With the two T1 mapping approaches (2SD and ROC) MVO- and 
MVO+ patients showed similar oedema volumes; however, T2W-SPAIR showed larger 
oedema volume measurements in the MVO+ group compared to the MVO- group (p<0.05). 
Measurements of myocardial salvage index did not differ significantly whether infarct size 
was measured from acute or follow-up LGE scans. However, with both T1 mapping 
thresholds, salvage index was significantly greater in the MVO- group compared to the 
MVO+ group (p<0.05 for both).  
Figure 3 shows examples of oedema highlighted by each of the three threshold 
methods. The areas delimited by each technique were similar; however, the T1 mapping ROC 
threshold highlighted a region of abnormal myocardium extending farther towards the lateral 
wall than that shown by the T2W 2SD approach. This region may be curtailed in the T2W 
2SD map as a consequence of subtle signal loss in the source images that is not detectable by 
 12      
 
eye. Of the three approaches, the T1 mapping 2SD gave the most conservative estimate of 
oedema volume in the example shown. 
 
Microvascular Obstruction Characterisation 
Figure 4 demonstrates that, in our study cohort, there is an exponential relationship 
between MVO extent and infarct size, with a strong, significant positive correlation between 
the two (Spearman’s rho = 0.73, p ≪0.001). Infarcts larger than 35% of the left ventricular 
myocardium tended to demonstrate large areas of MVO, whereas smaller infarcts tended to 
contain MVO no more than 5% of the total myocardial volume. Furthermore, three MVO+ 
patients exhibited the very low T1 values associated with haemorrhage. In these patients, 
direct measurement of T1 in haemorrhagic segments gave a median (range) T1 = 785 
(524-1025) ms.  
 
Inter- and Intra-Observer Reproducibility Results 
For segmental T1 mapping and T2W-SPAIR, inter-observer and intra-observer bias and 
limits of agreement were similar, with no statistically significant differences. ICCs were 0.91 
for T1 mapping and 0.84 for T2W-SPAIR. 
 
Discussion 
The main findings of this work are as follows: I) 3T native T1 mapping identifies 
oedematous myocardium one week post-acute-STEMI and has a better discriminatory 
performance than T2W-SPAIR; II) when using an optimised, ROC-derived threshold, T1 
mapping detects significantly larger oedema volumes than 2SD T2W-SPAIR, whereas with a 
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2SD threshold, T1 mapping yields similar oedema volumes to 2SD T2WSPAIR; III) in 
general, the presence of MVO does not significantly affect the performance of T1 mapping or 
T2W-SPAIR for identifying oedematous myocardium one week post STEMI; and (IV), 
typically, MVO is only found in medium-to-large MIs and its extent increases exponentially 
with infarct size. 
Myocardial salvage is an important predictor of mortality in patients with AMI,[25] but 
to date there is no gold standard for measuring myocardial oedema in vivo in humans. 
Several oedema imaging methods exist—single-photon emission computed tomography,[26] 
T2W CMR,[19] LGE endocardial surface area,[27] T1 mapping CMR,[3, 4, 23] and T2 
mapping CMR[13, 23]—but this study represents the first application of T1 mapping with a 
quantitative ROC-threshold optimised to a STEMI population. The precedent for such an 
approach was set by Ferreira et al.[28], in a recent study on myocarditis. This study showed 
that—with an appropriate T1 threshold—T1 mapping detects a significantly larger oedema 
volume than T2W imaging. In the current work we show similar findings in myocardial 
infarction patients; namely, the extent of oedema identified by our optimised ROC threshold 
method, one week post-MI, is significantly larger than that measured by T2W-SPAIR, except 
in MVO+ patients where the difference is not statistically significant. This builds on the pre-
clinical findings of O h-Ici et al.[29] and Ugander et al.[23], who have already demonstrated 
that T1 mapping can identify the area-at-risk, and the region so measured shows excellent 
correlation with microspheres. In the context of human studies, our work provides an 
interesting counterpoint to the findings of Dall’Armellina et al.[3] who noted that T1 mapping 
and T2W-SPAIR detected similar oedema volumes in STEMI patients 24 hours post-MI. The 
differences may lie in the way oedema was measured; indeed, when we employed the simple 
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2SD T1 threshold used by Dall’Armellina et al. at 1.5 T, our findings were consistent with 
theirs.  
In our patient cohort, we observed that remote myocardial segments—diametrically 
opposite the infarction—had significantly increased native T1 values compared to segments 
in age-matched healthy volunteers. There are two possible explanations for this important 
finding. First, in AMI the entire myocardium may suffer mild inflammation. Indeed, this 
hypothesis was put forward by other investigators who showed that ultra-small 
superparamagnetic particles of iron oxide are retained in segments very remote from the 
infarct.[27] Second, the T1 may have been abnormal in these patients prior to myocardial 
infarction, due to discrete microscopic fibrosis caused by comorbidities such as diabetes, 
hypertension or hypercholesterolemia.[30, 31] In order to establish which hypothesis is 
correct, our findings would have to be validated through histology. Given that our proposed 
ROC-derived threshold is free from any assumptions regarding remote myocardium, we 
believe it is more appropriate than T2W imaging for delimiting myocardial oedema in vivo. 
More than half of the patients included in this study exhibited MVO—demonstrating 
differentially worse cardiac remodelling and significantly higher levels of cardiac biomarkers 
than those that did not. They also showed comparable oedema volumes but lower salvage 
indices than MVO- patients, confirming the significance of MVO as an adverse prognostic 
marker in STEMI.[32] We included MVO in our T1 mapping and T2W SPAIR ROIs to 
establish its effect on the discriminatory power of these techniques. In patients with MVO, 
we observed that both methods are subtly—not significantly—influenced by haemorrhage, 
with 
some haemorrhagic pixels showing T1 values similar to those of normal myocardium, and 
much lower in some extreme examples, which also showed reduced T2W signal intensity 
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ratios. Despite this, T1 mapping was superior to T2W-SPAIR for detecting oedema, both 
overall and in the subgroup of patients without MVO. T1 mapping was also less prone to 
artefact than T2W-SPAIR, and its ICC was larger—though not significantly so. 
 
Study Limitations  
Due to time constraints, T2* mapping was not applied in this work, thus haemorrhage 
and MVO were both identified using LGE images alone. Furthermore, improvements have 
been made to the MOLLI T1 mapping pulse sequence since the beginning of the study, 
resulting in higher signal-to-noise, reduced artefact, shorter breath-holds and minimal T1 
heart-rate dependence—further increasing clinical utility. Our fixed T1 threshold value may 
differ slightly for other T1 mapping sequences, but this is to be expected due to different 
manufacturer setups, hardware and other factors. Further studies are required to determine 
appropriate T1 mapping ROC thresholds on other platforms. 
Given that this is a clinical study, histology would not have been a viable means of 
validating our technique; however, we and others have previously shown that T1 mapping 
reflects oedema in other acute pathologies in man.[4, 5] Human studies such as this are very 
important, as the immediate post-infarct stage represents a dynamic post-reperfusion healing 
process that differs between man and animal models. 
 
In conclusion, T1 mapping at 3T robustly detects myocardial oedema one week post-
AMI. Compared to standard T2W imaging, it shows superior discriminatory power and 
similar reproducibility, it can be applied with a receiver operator characteristic threshold—
rendering it independent of assumptions about the remote myocardium—and it describes 
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larger volumes of oedema. Neither T1 mapping nor T2W imaging were significantly affected 
by microvascular obstruction. 
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Figure Captions 
Figure 1: Representative short-axis CMR images—from a patient with no microvascular 
obstruction (MVO)(A-D), a small amount of MVO (E-H) and a large, confluent area of MVO 
(I-L). The top row shows an inferior myocardial infarction (infarct size 3% of total 
myocardium), middle and bottom rows are anteroseptal myocardial infarctions (infarct sizes 
33% and 57% respectively). T2-weighted spectral attenuated inversion recovery turbo spin 
echo (T2W-SPAIR TSE) images were acquired with repetition time (TR) = 1600 ms and echo 
time (TE) = 80 ms. Acute late gadolinium enhancement (LGE) images were acquired with a 
25° flip angle, TR/TE = 6.1/3.0 ms, and an inversion time chosen to optimise myocardial 
nulling. T1 maps and chi-square maps were generated from T1 mapping source images, which 
were acquired with a 3b(3b)3b(3b)5b sampling scheme, 35° flip angle, and TR/TE = 2.7/1.1 
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ms. The T1 map colour scale was chosen to highlight myocardium.
 
Figure 2: Receiver operator characteristic (ROC) curves—demonstrating the discriminatory 
power of T1 mapping (A) and T2-weighted spectral attenuated inversion recovery (T2W-
SPAIR)(B) for identifying myocardial oedema. Each of the plots are subdivided into 
microvascular obstruction (MVO)+ and MVO- patient groups. No statistically significant 
differences were seen between the MVO+/- groups with either method, but T1 mapping gave 
a significantly larger area-under-the-curve (AUC) than T2W-SPAIR. 
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Figure 3: Basal short-axis images with visual thresholds—(A) a T2-weighted spectral 
attenuated inversion recovery (T2W-SPAIR) image with a 2SD threshold, (B) a T1 map with 
a 2SD threshold, (C) a T1 map with a receiver operator characteristic (ROC)-derived 
threshold. Highlighted regions (delimiting elevated signal intensity or T1 values) are visible 
in the inferior part of the myocardium, corresponding to late gadolinium enhancement. Green 
and red lines denote epicardial and endocardial borders, respectively. 
 
Figure 4: Plot showing the extent of microvascular obstruction (MVO) versus infarct 
size, as measured by late gadolinium enhancement (LGE) imaging - both are measured 
as a percentage of the total myocardium. Very large volumes of MVO (>5%) can be 
seen in larger infarcts (>35% of total myocardium). An exponential regression line 
indicates the tendency for MVO size to increase with infarct size. 
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Table 1. General and CMR Patient 
Characteristics 
All Patients 
(n=62) 
MVO-  
(n=27) 
MVO+  
(n=35) 
Age [Median (range) yrs] 59 (29-88) 60 (46-83) 58 (29-88) 
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Male gender [%] 46 (74%) 18 (67%) 28 (80%) 
BSA [Median (range) m2] 1.96 (1.48-2.35) 1.95 (1.48-2.22) 1.99 (1.53-2.35) 
Heart Rate [Median (range) bpm] 65 (50-85) 62 (53-70)* 68 (50-85)* 
Risk Factors [n (%)]    
-Diabetes Mellitus 5 (8%) 1 (4%) 4 (11%) 
-Smoking 24 (39%) 10 (37%) 14 (40%) 
-Hypertension 11 (18%) 3 (11%) 8 (23%) 
-Hypercholesterolemia 27 (24%) 8 (30%) 9 (26%) 
-Prior Angina 1 (2%) 1 (4%) 0 (0%) 
Troponin I (12 Hr) [Median (range) 
ng/ml] 
64 (2-461) 43 (2-155)* 97 (16-461)* 
Time Onset C/P to PCI [Median (range) 
hrs] 
2.7 (0.8-12.0) 3.3 (0.8-12.0) 4.1 (1.1-8.2) 
Time PCI to CMR [Days] 7 7 7 
Culprit Artery    
-LAD 25 (40%) 4 (15%) 21 (60%) 
-LCX 3 (5%) 0 (0%) 3 (9%) 
-RCA 34 (55%) 23 (85 %) 11 (31%) 
LVEDV [Mean (SD) ml] 164 (37) 146 (30)* 179 (37)* 
LVESV [Mean (SD) ml] 84 (33) 65 (21)* 100 (32)* 
EF [Mean (SD) %] 50 (10) 57 (7)* 45 (9)* 
LVM [Mean (SD) ml] 147 (45) 130 (42) 161 (44) 
Indexed LVEDV [Mean (SD) ml] 84 (17) 76 (11)* 90 (18)* 
Indexed LVESV [Mean (SD) ml] 43 (16) 33 (9)* 51 (16)* 
LVM Index [Mean (SD) g/m2] 75 (20) 67 (18) 81 (19) 
    
Table 1. Patient characteristics - * denotes a statistically significant difference between 
MVO+ and MVO- groups (p<0.05), with specific p-values shown in the text. BSA = body 
surface area, C/P = chest-pain, CMR = cardiovascular magnetic resonance, EF = ejection 
fraction, LVEDV = left ventricular end-diastolic volume, LVESV = left ventricular end-
systolic volume, LVM = left ventricular mass, PCI = percutaneous coronary intervention, 
RCA. 
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Table 2. Myocardium at Risk and 
Salvage Index 
All Patients  MVO-  MVO+  
Oedema Volume (%)    
-T2W-SPAIR 2SD 40 (16) 28 (11)† 48 (13)† 
-T1 Mapping 2SD 37 (9) 37 (12) 38 (7)* 
-T1 Mapping ROC 55 (7)* 57 (7)* 53 (8) 
Salvage Index    
-1 Week: T2W-SPAIR 2SD 0.66 (0.23) 0.75 (0.17) 0.59 (0.25) 
-1 Week: T1 Mapping 2SD 0.59 (0.35) 0.84 (0.09)† 0.42 (0.36)† 
-1 Week: T1 Mapping ROC 0.73 (0.22) 0.89 (0.08)*† 0.63 (0.22)† 
-6 Months: T2W-SPAIR 2SD 0.56 (0.25) 0.69 (0.29) 0.51 (0.22) 
-6 Months: T1 Mapping 2SD 0.51 (0.30) 0.76 (0.19)† 0.39 (0.30)† 
-6 Months: T1 Mapping ROC 0.67 (0.21) 0.85 (0.12)*† 0.59 (0.21)† 
Table 2. Myocardial oedema volume and salvage index measured using T2W-SPAIR and T1 
mapping - Data are presented as mean (SD).* denotes a statistically significant difference 
between T1 mapping with a two standard deviation (2SD) or receiver operator characteristic 
(ROC) threshold and T2-weighted spectral attenuated inversion recovery (T2W-SPAIR); y 
denotes a statistically significant difference between microvascular-obstruction-positive 
(MVO+) and microvascular-obstruction-negative (MVO-) groups (p values in the text). No 
significant difference was seen between salvage index measurements made using infarct size 
at one week and infarct size at six months. 
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